Actively Recruiting
Comorbidity Management in Rheumatic Disease.
Led by Western University, Canada · Updated on 2025-10-07
199
Participants Needed
1
Research Sites
85 weeks
Total Duration
On this page
Sponsors
W
Western University, Canada
Lead Sponsor
C
Canadian Rheumatology Association (CIORA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Rheumatoid arthritis is a disease where the immune system attacks the body by mistake, causing inflammation of the joints and other body parts. People with rheumatoid arthritis are at higher risk of infections, heart problems, and bone issues compared to others. They regularly see rheumatologists, arthritis care physicians, to manage their disease. However, managing these other health problems alongside their main treatment is difficult for rheumatologists due to limited resources. This clinical study is being conducted to see if adding a family doctor to a team of rheumatologists can help. Rheumatologists will complete a case report form about the patient's health and send them to a special family physician clinic. This clinic will focus on improving vaccination against diseases, heart health, and bone strength. They will check if patients need special vaccines to protect them from infections. They will screen for heart disease using blood pressure measurements, and order blood work for high cholesterol and diabetes if needed. They will also review bone health and send people for tests to check their bone density if needed. A change in routines and medications may be recommended after their checkup. Rheumatologists will complete another case report about the patient's health 6 months after their family doctor appointment. The study will assess how these markers of health management improve after this family doctor joins the team. It hopes to prove that this new way of working in the community will give people with rheumatoid arthritis better protection against certain infections, heart problems and weak bones.
CONDITIONS
Official Title
Comorbidity Management in Rheumatic Disease.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of the Waterloo Rheumatology Community Clinic
- Aged 18 to 80 years of age
- Diagnosis of rheumatoid arthritis
- Minimum of limited working proficiency in English
- No significant cognitive impairment that can inhibit their ability to engage in the study
You will not qualify if you...
- Age less than 18 years or greater than 80 years
- Significant cognitive impairment that impedes ability to engage in the study
- Unwilling to participate in the study
- Patients currently pregnant will be excluded from the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Waterloo Rheumatology
Waterloo, Ontario, Canada, N2T 0C2
Actively Recruiting
Research Team
C
Cassandra Schulz, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here